4//SEC Filing
Arman Arvin Cyrus 4
Accession 0001104659-23-022094
CIK 0001175680other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:09 PM ET
Size
8.4 KB
Accession
0001104659-23-022094
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Arman Arvin Cyrus
President
Transactions
- Award
Common Stock
2023-02-13+434,782→ 1,081,334 total - Award
Warrants (right to buy)
2023-02-13+434,782→ 434,782 totalExercise: $0.50→ Common Stock (434,782 underlying)
Footnotes (3)
- [F1]The reported securities are included within Units purchased by the reporting person in a private placement directly with the Company. The terms are identical to a concurrent offering being conducted through a placement agent (the "Offering"). Each "Unit" consists of one share of common stock and one warrant to purchase one share of common stock.
- [F2]The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price.
- [F3]The warrants will become exercisable in full on the final closing date of the Offering. The warrants will expire five years after the exercise date.
Documents
Issuer
CytoDyn Inc.
CIK 0001175680
Entity typeother
Related Parties
1- filerCIK 0001939191
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 8:09 PM ET
- Size
- 8.4 KB